Razieh Soltani Arabshahi, MD
NPI 1033423413ActiveIndividual· Dermatology, MOHS-Micrographic Surgery· Pasadena, CA
Dermatology, MOHS-Micrographic Surgery (MD) with David Denenholz MD Inc, practicing in Pasadena, California. 786 Medicare patients in 2024, $437,749 paid; nearly all of their 664 Part D prescriptions were generic (94%). Genzyme Corporation was the largest of 13 companies reporting payments in 2025, $1,131 in all, mostly food and beverage.
Overview
| NPI | 1033423413 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | Yes |
| NPI issued | Jul 28, 2010 |
| Last updated in NPPES | Aug 14, 2018 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Dermatology, MOHS-Micrographic Surgery Primary | 207ND0101X | 35.123120 | CA |
| Dermatology | 207N00000X | 35.123120 | CA |
| Dermatology | 207N00000X | 35.123120 | OH |
| Dermatology, MOHS-Micrographic Surgery | 207ND0101X | A156592 | CA |
| Dermatology, MOHS-Micrographic Surgery | 207ND0101X | 35.123120 | OH |
| Dermatology, Procedural Dermatology | 207NS0135X | A156592 | CA |
| Dermatology, Procedural Dermatology | 207NS0135X | 35.123120 | OH |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Dermatology (CA) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 786 |
|---|---|
| Services billed | 4,185 across 82 procedure codes |
| Paid by Medicare | $437,749 |
Part D prescriptions in 2024
| Prescriptions (claims) | 664 · 788 30-day fills |
|---|---|
| Patients | 326 |
| Total drug cost | $427,163 |
| Generic share | 94% of claims |
Education and affiliations
| Graduation year | 2002 |
|---|---|
| Medicare specialty | Dermatology |
Medical group
- David Denenholz MD IncPasadena, CA · 4 clinicians
Industry payments (Open Payments)
- 2025$1,131 · 37 payments from 13 companies
- 2024$1,277 · 41 payments from 13 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Genzyme Corporation | $359.99 | 9 |
| Galderma Laboratories, L.P. | $259.61 | 7 |
| Regeneron Healthcare Solutions, Inc. | $146.03 | 4 |
| Incyte Corporation | $81.99 | 3 |
| Leo Pharma Inc. | $60.54 | 3 |
What the 2025 payments were for
- Food and Beverage$1,131 · 37 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Dermatology, MOHS-Micrographic Surgery providers in Pasadena
- 1518447689
All Dermatology, MOHS-Micrographic Surgery providers in California →